DSD-C275

46,XY DSD (likely ovotesticular DSD or mixed gonadal dysgenesis; with gonadal germ cell tumor) · 46,XY · DSD-C275

DSD-C275 · Ovotesticular DSD · 2021

Karyotype 46,XY · Phenotypes HPO:0000054, HPO:0000062, HPO:0000771, Micropenis (HP:0000054), Ambiguous genitalia (HP:0000062), Gynecomastia (HP:0000771)

46,XY DSD (likely ovotesticular or mixed gonadal dysgenesis) with metastatic gonadal dysgerminoma.

Images · 1

Case fields and evidence

Category

46,XY DSD (likely ovotesticular DSD or mixed gonadal dysgenesis; with gonadal germ cell tumor)

Age

24 years old (ambiguous genitalia at birth; bilateral breast development and phallic enlargement at age 10; cyclic hematuria at age 12; presented at 24 with abdominal pain and mass)

Sex

Raised male (male social sex); predominantly male phenotype

Karyotype

46,XY

Phenotypes

Micropenis (HP:0000054); Ambiguous genitalia (HP:0000062); Gynecomastia (HP:0000771)

Diagnosis

46,XY DSD (likely ovotesticular or mixed gonadal dysgenesis) with metastatic gonadal dysgerminoma.

Follow-up

Postoperative course uneventful; planned at least 2 more chemo cycles then genital reconstructive surgery; no long-term follow-up outcome provided.

General phenotype

Predominantly male phenotype with ambiguous genitalia, bilateral gynecomastia and cyclic hematuria; large mobile abdominopelvic mass.

Imaging

MRI showed uterus and two well-defined abdominopelvic masses (14.4x8.5 cm and 15x9 cm), likely gonadal origin by vasculature; PET-CT showed FDG-avid lymph nodes in abdomen, mediastinum, neck, left axilla, diaphragm and bilateral lung lesions; genitogram inconclusive.

Laboratory findings

Low testosterone, DHEAS and AMH; LH, FSH and estradiol (E2 75.9) within normal limits; beta-HCG, CA19-9, AFP, CEA normal but CA125 (128.6) and LDH (600) elevated; LH surge during admission followed by hematuria.

Management

Psychological evaluation; patient wished to remain male. Neoadjuvant chemo (carboplatin + etoposide, EP) one cycle, then febrile neutropenia, AKI (tumor lysis syndrome); later laparotomy for pain/fever: resection of bilateral adnexal masses (twisted necrotic left 15x11x8 cm, right 10x6x4 cm), subtotal hysterectomy (cervix 2-3 cm retained), omentectomy, adhesiolysis.

Pathology

US-guided FNAC: tumor cells with vesicular chromatin, prominent nucleoli, tigroid background; admixed sarcoid-like granulomas, lymphocytes, occasional multinucleated giant cells; IHC SALL4 and OCT4 positive, CD30 and AFP negative, consistent with dysgerminoma. Laparotomy specimen: bilateral adnexal large necrotic/hemorrhagic/calcified masses, no viable tumor or normal ovarian cortex; uterus 4x3x1 cm with proliferative endometrium, normal tubes.

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Genetics

See source

Cite this resource

DSD Research Library | 46,XY DSD (likely ovotesticular DSD or mixed gonadal dysgenesis; with gonadal germ cell tumor) · 46,XY · DSD-C275 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C275?version=v1.4.0